Acne News

CHICAGO — With proper counseling and parameters, aggressive acne scarring treatments can be used in patients with skin of color, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting.

Newly FDA-approved IDP-126 gel improved quality of life outcomes in patients with acne vulgaris over vehicle, according to a study.

An anonymous web-based survey found that respondents with skin of color reported emotional burdens from their skin diseases, as well as a belief that most dermatologists do not have the proper training to treat their skin type.

The FDA has approved IDP-126 for the treatment of acne in patients aged 12 years and older, Bausch Health announced in a press release.

Each year, WHO marks World Mental Health Day on Oct. 10 in an effort to raise awareness of mental health issues around the world and mobilize efforts to support mental health.

NEW YORK — Dermatologists must treat post-inflammatory hyperpigmentation simultaneously with acne in patients with skin of color, which can be done using lasers, according to a study presented here.

Patients in sexual and gender minorities who have chronic inflammatory skin diseases often experience financial and non-financial barriers to care, according to a study.

IDP-126 gel, which is a combination of clindamycin, adapalene and benzoyl peroxide, showed positive results in patients with moderate to severe acne, according to a study.

In this edition, M-PDT efficacy similar to isotretinoin in acne vulgaris; Spitz neoplasm diagnosis in adults; immunotherapy treatment shows promise in basal cell carcinoma and more.

Modified 5-aminolevulinic acid photodynamic therapy was as effective as isotretinoin in the treatment of severe acne with a faster onset, according to a small study.